Will the global demand for fast, effective vaccines transform the vaccine space? Historically vaccines have been made from modified pathogenic agents employed to produce active
Since the onset of the SARS-CoV-2 pandemic, companies moved quickly to produce rapid antigen tests that could detect SARS-CoV-2 cases within minutes compared with hours
Although several COVID19 vaccines have been approved and population immunity rates are increasing, it will still be a long time until everyone is immune. Until
One year after the SARS-CoV-2 was declared a pandemic, over 110 million cases and 2.5 million deaths worldwide, unprecedented lockdowns, quarantines and economic devastation, several vaccine candidates have been approved by regulatory authorities. But what do the emergence of new SARS-CoV-2 mean for vaccination and the end of the global pandemic?
Will the global demand for fast, effective vaccines transform the vaccine space? Historically vaccines have been made from modified pathogenic agents employed to produce active
Since the onset of the SARS-CoV-2 pandemic, companies moved quickly to produce rapid antigen tests that could detect SARS-CoV-2 cases within minutes compared with hours
Although several COVID19 vaccines have been approved and population immunity rates are increasing, it will still be a long time until everyone is immune. Until
One year after the SARS-CoV-2 was declared a pandemic, over 110 million cases and 2.5 million deaths worldwide, unprecedented lockdowns, quarantines and economic devastation, several vaccine candidates have been approved by regulatory authorities. But what do the emergence of new SARS-CoV-2 mean for vaccination and the end of the global pandemic?
Subscribe to receive product updates & promotions.
